ArticleThe ocular surface2026
Prolonged stability of 1% 5-FU eye drops as topical chemotherapy for ocular surface squamous neoplasia.
Michael Antonietti, Despoina Theotoka, Mak B Djulbegovic, Gregory S Gorman, Matthew Massey, Anat Galor, Carol L Karp
Abstract readLetter
In one paragraphArticle in The ocular surface, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Michael AntoniettiDepartment of Ophthalmology, Massachusetts Eye and Ear Infirmary, Havard Medical School, Boston, MA, USA.
Despoina TheotokaDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Mak B DjulbegovicWills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.
Gregory S GormanMcWhorter School of Pharmacy, Samford University, Birmingham, AL, USA.
Matthew MasseyMassey Drugs-Cloverdale, Florence, AL, USA.
Anat GalorDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Carol L KarpDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: ckarp@med.miami.edu.
Funding
Shared Equipment ModuleP30EY014801 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Victor L Perez · 2004 to 2026
$12.2MDifferentiation of Clinical Phenotypes of Inflammatory and Neuropathic Ocular Pain Conditions with Morphologic Measures and Functional Brain ImagingU01EY034686 · NEI · BOSTON CHILDREN'S HOSPITAL · PI Eric Alan Moulton · 2022 to 2026
$4.7MDefining bacterial members of the ocular surface microbiome and assessing stability over timeU24EY035102 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GALOR, ANAT, ST LEGER, ANTHONY J · 2023 to 2025
$3.3MTear protein biomarkers of refractive surgery painR33EY032468 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI AICHER, SUE A, GALOR, ANAT · 2023 to 2025
$2.9MBLRD VA I01 BX004893CSRD VA I01 CX002015CSRD VA I01 CX002633NEI NIH HHS P30 EY014801NEI NIH HHS R33 EY032468NEI NIH HHS U01 EY034686NEI NIH HHS U24 EY035102RRD VA I21 RX003883
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
5-FUOcular surface squamous neoplasia (OSSN)StabilityTopical 5-fluorouracilTopical chemotherapy
Identifiers
PMID41672144
PMCPMC13401981
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390